Mechanisms of environmental influence on human autoimmunity: A national institute of environmental health sciences expert panel workshop

Journal of Autoimmunity

Volumn 39, Issue 4, 2012, Pages 272-284

  Selmi, Carlo ^a,b   Leung, Patrick S C ^a   Sherr, David H ^c   Diaz, Marilyn ^d   Nyland, Jennifer F ^e   Monestier, Marc ^f   Rose, Noel R ^g   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adjuvant; Antigen modification; Epigenetics; Tolerance breakdown

Indexed keywords

AUTOANTIBODY; BACTERIAL DNA; BACTERIAL PROTEIN; BACTERIAL TOXIN; CPG OLIGODEOXYNUCLEOTIDE; FLAGELLIN; HEMOZOIN; IMIDAZOQUINOLINE DERIVATIVE; IMMUNOLOGICAL ADJUVANT; ISCOM; LIPID A; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; LIPOPROTEIN; LIPOTEICHOIC ACID; MINERAL OIL; PORIN; PRISTANE; PROFILIN; SINGLE STRANDED RNA; SQUALENE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; VIRUS RNA; XENOBIOTIC AGENT;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BACTERIAL INFECTION; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; EPIGENETICS; GENETIC ASSOCIATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR MIMICRY; MONOZYGOTIC TWINS; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TH17 CELL; ULTRAVIOLET RADIATION; VIRUS INFECTION;

ADAPTIVE IMMUNITY; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BIOLOGICAL AGENTS; CONGRESSES AS TOPIC; ENVIRONMENTAL POLLUTANTS; EPIGENESIS, GENETIC; GENE-ENVIRONMENT INTERACTION; HUMANS; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; SPLEEN; TOLL-LIKE RECEPTORS;

EID: 84869863290     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.05.007     Document Type: Review

References (138)

1. Barrett J.C., Clayton D.G., Concannon P., Akolkar B., Cooper J.D., Erlich H.A., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009, 41(6):703-707.
2. Liu X., Invernizzi P., Lu Y., Kosoy R., Bianchi I., Podda M., et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010, 42:658-660.
3. Radstake T.R., Gorlova O., Rueda B., Martin J.E., Alizadeh B.Z., Palomino-Morales R., et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 2010, 42:426-429.
4. Sanchez E., Palomino-Morales R.J., Ortego-Centeno N., Jimenez-Alonso J., Gonzalez-Gay M.A., Lopez-Nevot M.A., et al. Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. Hum Mol Genet 2009, 18:3739-3748.
5. Stahl E.A., Raychaudhuri S., Remmers E.F., Xie G., Eyre S., Thomson B.P., et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010, 42:508-514.
6. Hemminki K., Li X., Sundquist J., Sundquist K. The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun 2010, 34:J307-J313.
7. Chandran V., Raychaudhuri S.P. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010, 34:J314-J321.
8. Costenbader K.H., Gay S., Riquelme M.E., Iaccarino L., Doria A. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?. Autoimmun Rev 2011, [Epub ahead of print].
9. Miller F.W., Pollard K.M., Parks C.G., Germolec D., Leung P.S., Selmi C., et al. Approaches for developing criteria for environmentally associated autoimmune diseases. J Autoimmun 2012, 39(4):253-258.
10. Mills K.H. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 2011, 11:807-822.
11. Lee T.P., Tang S.J., Wu M.F., Song Y.C., Yu C.L., Sun K.H. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes. J Autoimmun 2010, 35:358-367.
12. Lien E., Zipris D. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. Curr Mol Med 2009, 9:52-68.
13. Mavragani C.P., Crow M.K. Activation of the type I interferon pathway in primary Sjogren's syndrome. J Autoimmun 2010, 35(3):225-231.
14. Routsias J.G., Tzioufas A.G. Autoimmune response and target autoantigens in Sjogren's syndrome. Eur J Clin Invest 2010, 40(11):1026-1036.
15. Zhou X.J., Lv J.C., Cheng W.R., Yu L., Zhao M.H., Zhang H. Association of TLR9 gene polymorphisms with lupus nephritis in a Chinese Han population. Clin Exp Rheumatol 2010, 28:397-400.
16. Gao F., Brant K.A., Ward R.M., Cattley R.T., Barchowsky A., Fabisiak J.P. Multiple protein kinase pathways mediate amplified IL-6 release by human lung fibroblasts co-exposed to nickel and TLR-2 agonist, MALP-2. Toxicol Appl Pharmacol 2010, 247:146-157.
17. Gardner R.M., Nyland J.F., Evans S.L., Wang S.B., Doyle K.M., Crainiceanu C.M., et al. Mercury induces an unopposed inflammatory response in human peripheral blood mononuclear cells in vitro. Environ Health Perspect 2009, 117:1932-1938.
18. Meroni P.L. Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): old truths and a new syndrome?. J Autoimmun 2011, 36:1-3.
19. Agmon-Levin N., Hughes G.R., Shoenfeld Y. The spectrum of ASIA: 'autoimmune (auto-inflammatory) syndrome induced by adjuvants'. Lupus 2012, 21:118-120.
20. Shoenfeld Y., Agmon-Levin N. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011, 36:4-8.
21. Kanta H., Mohan C. Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation. Genes Immun 2009, 10:390-396.
22. Shlomchik M.J. Sites and stages of autoreactive B cell activation and regulation. Immunity 2008, 28:18-28.
23. von Boehmer H., Melchers F. Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol 2010, 11:14-20.
24. Wang C., Pan H.F., Ye D.Q. The therapeutic potential of the targeted autoreactive B lymphocytes by rituximab in SLE. Autoimmun Rev 2012, 11:373.
25. Jiang C., Zhao M.L., Scearce R.M., Diaz M. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. Arthritis Rheum 2011, 63(4):1086-1096.
26. Moritoki Y., Zhang W., Tsuneyama K., Yoshida K., Wakabayashi K., Yang G.X., et al. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology 2009, 136:1037-1047.
27. Dorner T., Jacobi A.M., Lipsky P.E. B cells in autoimmunity. Arthritis Res Ther 2009, 11:247.
28. DiLillo D.J., Matsushita T., Tedder T.F. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 2010, 1183:38-57.
29. Bouaziz J.D., Yanaba K., Tedder T.F. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008, 224:201-214.
30. Matsushita T., Tedder T.F. Identifying regulatory B cells (B10 cells) that produce IL-10 in mice. Methods Mol Biol 2011, 677:99-111.
31. Strickland F.M., Hewagama A., Lu Q., Wu A., Hinderer R., Webb R., et al. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. J Autoimmun 2012, 38:J135-J143.
32. Reynolds J.M., Pappu B.P., Peng J., Martinez G.J., Zhang Y., Chung Y., et al. Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity 2010, 32:692-702.
33. Tzartos J.S., Friese M.A., Craner M.J., Palace J., Newcombe J., Esiri M.M., et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2008, 172:146-155.
34. Durrant D.M., Metzger D.W. Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol Invest 2010, 39:526-549.
35. Sarra M., Pallone F., Macdonald T.T., Monteleone G. IL-23/IL-17 axis in IBD. Inflamm Bowel Dis 2010, 16:1808-1813.
36. Di Cesare A., Di Meglio P., Nestle F.O. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 2009, 129:1339-1350.
37. Sarkar S., Fox D.A. Targeting IL-17 and Th17 cells in rheumatoid arthritis. Rheum Dis Clin North Am 2010, 36:345-366.
38. Segal B.M. Th17 cells in autoimmune demyelinating disease. Semin Immunopathol 2010, 32:71-77.
39. Elliott M., Benson J., Blank M., Brodmerkel C., Baker D., Sharples K.R., et al. Ustekinumab: lessons learned from targeting interleukin-12/23p40 in immune-mediated diseases. Ann N Y Acad Sci 2009, 1182:97-110.
40. Quintana F.J., Weiner H.L. Environmental control of Th17 differentiation. Eur J Immunol 2009, 39:655-657.
41. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
42. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
43. Kimura A., Naka T., Nohara K., Fujii-Kuriyama Y., Kishimoto T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci U S A 2008, 105:9721-9726.
44. Yu H., Yang Y.H., Rajaiah R., Moudgil K.D. Nicotine-induced differential modulation of autoimmune arthritis in the Lewis rat involves changes in IL-17 and anti-cyclic citrullinated peptide antibodies. Arthritis Rheum 2011, 63(4):981-991.
45. Page K., Zhou P., Ledford J.R., Day S.B., Lutfi R., Dienger K., et al. Early immunological response to German cockroach frass exposure induces a Th2/Th17 environment. J Innate Immun 2010, 3(2):167-179.
46. Ho P.P., Steinman L. The aryl hydrocarbon receptor: a regulator of Th17 and Treg cell development in disease. Cell Res 2008, 18:605-608.
47. Marshall N.B., Kerkvliet N.I. Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells. Ann N Y Acad Sci 2010, 1183:25-37.
48. Buckner J.H. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010, 10:849-859.
49. Shapira Y., Agmon-Levin N., Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010, 34:J168-J177.
50. Ranque B., Mouthon L. Geoepidemiology of systemic sclerosis. Autoimmun Rev 2010, 9:A311-A318.
51. Moroni L., Bianchi I., Lleo A. Geoepidemiology, gender and autoimmune disease. Autoimmun Rev 2012, 11:A386-A392.
52. Sellner J., Kraus J., Awad A., Milo R., Hemmer B., Stuve O. The increasing incidence and prevalence of female multiple sclerosis-a critical analysis of potential environmental factors. Autoimmun Rev 2011, 10:495-502.
53. Awasthi A., Murugaiyan G., Kuchroo V.K. Interplay between effector Th17 and regulatory T cells. J Clin Immunol 2008, 28:660-670.
54. Chatila T. Molecular mechanisms of regulatory T cell development. J Clin Immunol 2008, 28:625-630.
55. Gupta S. Immune homeostasis: regulatory T cells (Treg) and molecules. J Clin Immunol 2008, 28:617-618.
56. Funatake C.J., Marshall N.B., Kerkvliet N.I. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation of alloreactive CD8+ T cells toward a regulatory T cell phenotype by a mechanism that is dependent on aryl hydrocarbon receptor in CD4+ T cells. J Immunotoxicol 2008, 5:81-91.
57. Apetoh L., Quintana F., Pot C., Joller N., Xiao S., Kumar D., et al. The aryl hydrocarbon receptor (AhR) interacts with c-Maf to promote the differentiation of IL-27-induced regulatory type 1 (Tr1) cells. Nat Immunol 2010, 11(9):854-861.
58. Gandhi R., Kumar D., Burns E.J., Nadeau M., Dake B., Laroni A., et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat Immunol 2010, 11:846-853.
59. Hill J.A., Feuerer M., Tash K., Haxhinasto S., Perez J., Melamed R., et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007, 27:786-800.
60. Mezrich J.D., Fechner J.H., Zhang X., Johnson B.P., Burlingham W.J., Bradfield C.A. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 2010, 185(6):3190-3198.
61. Kerkvliet N.I. AHR-mediated immunomodulation: the role of altered gene transcription. Biochem Pharmacol 2009, 77:746-760.
62. Marshall N.B., Vorachek W.R., Steppan L.B., Mourich D.V., Kerkvliet N.I. Functional characterization and gene expression analysis of CD4+ CD25+ regulatory T cells generated in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Immunol 2008, 181:2382-2391.
63. Baban B., Chandler P.R., Sharma M.D., Pihkala J., Koni P.A., Munn D.H., et al. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 2009, 183:2475-2483.
64. Hauben E., Gregori S., Draghici E., Migliavacca B., Olivieri S., Woisetschlager M., et al. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 2008, 112:1214-1222.
65. Vogel C.F., Goth S.R., Dong B., Pessah I.N., Matsumura F. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun 2008, 375:331-335.
66. Favre D., Mold J., Hunt P.W., Kanwar B., Loke P., Seu L., et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2010, 2. 32ra6.
67. DiNatale B.C., Murray I.A., Schroeder J.C., Flaveny C.A., Lahoti T.S., Laurenzana E.M., et al. Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci 2010, 115:89-97.
68. Kerkvliet N.I., Steppan L.B., Vorachek W., Oda S., Farrer D., Wong C.P., et al. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3 T cells in pancreatic lymph nodes. Immunotherapy 2009, 1:539-547.
69. Allan L.L., Sherr D.H. Disruption of human plasma cell differentiation by an environmental polycyclic aromatic hydrocarbon: a mechanistic immunotoxicological study. Environ Health 2010, 9:15.
70. Martin B., Hirota K., Cua D.J., Stockinger B., Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31:321-330.
71. Ishimaru N., Takagi A., Kohashi M., Yamada A., Arakaki R., Kanno J., et al. Neonatal exposure to low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin causes autoimmunity due to the disruption of T cell tolerance. J Immunol 2009, 182:6576-6586.
72. le Maire A., Grimaldi M., Roecklin D., Dagnino S., Vivat-Hannah V., Balaguer P., et al. Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors. EMBO Reports 2009, 10:367-373.
73. Hontecillas R., Bassaganya-Riera J. Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis. J Immunol 2007, 178:2940-2949.
74. Guri A.J., Mohapatra S.K., Horne W.T., Hontecillas R., Bassaganya-Riera J. The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease. BMC Gastroenterol 2010, 10:60.
75. Mucida D., Pino-Lagos K., Kim G., Nowak E., Benson M.J., Kronenberg M., et al. Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells. Immunity 2009, 30:471-472. author reply 2-3.
76. Pollard K.M. Gender differences in autoimmunity associated with exposure to environmental factors. J Autoimmun 2012, 38:J177-J186.
77. Maeda A., Beissert S., Schwarz T., Schwarz A. Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells. J Immunol 2008, 180:3065-3071.
78. Shintani Y., Yasuda Y., Kobayashi K., Maeda A., Morita A. Narrowband ultraviolet B radiation suppresses contact hypersensitivity. Photodermatol Photoimmunol Photomed 2008, 24:32-37.
79. Lehmann P., Homey B. Clinic and pathophysiology of photosensitivity in lupus erythematosus. Autoimmun Rev 2009, 8:456-461.
80. Papini A.M. The use of post-translationally modified peptides for detection of biomarkers of immune-mediated diseases. J Pept Sci 2009, 15:621-628.
81. Selmi C., Meda F., Kasangian A., Invernizzi P., Tian Z., Lian Z., et al. Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol 2010, 7:1-10.
82. Mackay I.R. Autoimmunity since the 1957 clonal selection theory: a little acorn to a large oak. Immunol Cell Biol 2008, 86:67-71.
83. Jacobson E.M., Huber A., Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 2008, 30:58-62.
84. Odin J.A., Huebert R.C., Casciola-Rosen L., LaRusso N.F., Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 2001, 108:223-232.
85. Sasaki M., Ikeda H., Nakanuma Y. Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21WAF1/Cip1 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study. J Autoimmun 2008, 31:73-78.
86. Harauz G., Musse A.A. A tale of two citrullines-structural and functional aspects of myelin basic protein deimination in health and disease. Neurochem Res 2007, 32:137-158.
87. Moscarello M.A., Mastronardi F.G., Wood D.D. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res 2007, 32:251-256.
88. Pollard K.M., Lee D.K., Casiano C.A., Bluthner M., Johnston M.M., Tan E.M. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J Immunol 1997, 158:3521-3528.
89. Havarinasab S., Hultman P. Organic mercury compounds and autoimmunity. Autoimmun Rev 2005, 4:270-275.
90. Wegner N., Lundberg K., Kinloch A., Fisher B., Malmstrom V., Feldmann M., et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010, 233:34-54.
91. Cooper G.S., Bynum M.L., Somers E.C. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009, 33:197-207.
92. Lleo A., Selmi C., Invernizzi P., Podda M., Coppel R.L., Mackay I.R., et al. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 2009, 49:871-879.
93. Lleo A., Bowlus C.L., Yang G.X., Invernizzi P., Podda M., Van de Water J., et al. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology 2010, 52:987-998.
94. Lleo A., Shimoda S., Ishibashi H., Gershwin M.E. Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes. J Gastroenterol 2011, 46(Suppl. 1):29-38.
95. Selmi C., Maria Papini A., Pugliese P., Claudia Alcaro M., Gershwin M.E. Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis. Arch Med Sci 2011, 7:368-380.
96. Dupont C., Armant D.R., Brenner C.A. Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med 2009, 27:351-357.
97. Ezhkova E., Pasolli H.A., Parker J.S., Stokes N., Su I.H., Hannon G., et al. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 2009, 136:1122-1135.
98. Breton C.V., Salam M.T., Vora H., Gauderman W.J., Gilliland F.D. Genetic variation in the glutathione synthesis pathway, air pollution, and children's lung function growth. Am J Respir Crit Care Med 2011, 183:243-248.
99. Zhang H., Zhu Z., Meadows G.G. Chronic alcohol consumption decreases the percentage and number of NK cells in the peripheral lymph nodes and exacerbates B16BL6 melanoma metastasis into the draining lymph nodes. Cell Immunol 2011, 266:172-179.
100. Baccarelli A., Wright R.O., Bollati V., Tarantini L., Litonjua A.A., Suh H.H., et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med 2009, 179:572-578.
101. Matthias T., Shoenfeld Y. Challenges for the autoimmunologist. Clin Rev Allergy Immunol 2010, 38:75-76.
102. Shoenfeld Y., Selmi C., Zimlichman E., Gershwin M.E. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008, 31:325-330.
103. Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun 2010, 34:J300-J306.
104. Tobon G.J., Youinou P., Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun 2010, 35:10-14.
105. Clancy R.M., Marion M.C., Kaufman K.M., Ramos P.S., Adler A., Harley J.B., et al. Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus. Arthritis Rheum 2010, 62:3415-3424.
106. Cunninghame Graham D.S. Genome-wide association studies in systemic lupus erythematosus: a perspective. Arthritis Res Ther 2009, 11:119.
107. Han J.W., Zheng H.F., Cui Y., Sun L.D., Ye D.Q., Hu Z., et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009, 41:1234-1237.
108. Kariuki S.N., Franek B.S., Kumar A.A., Arrington J., Mikolaitis R.A., Utset T.O., et al. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Res Ther 2010, 12:R151.
109. Yang W., Shen N., Ye D.Q., Liu Q., Zhang Y., Qian X.X., et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 2010, 6:e1000841.
110. Korganow A.S., Knapp A.M., Nehme-Schuster H., Soulas-Sprauel P., Poindron V., Pasquali J.L., et al. Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: decreased memory B cells and membrane CD19 expression. J Autoimmun 2010, 34:426-434.
111. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
112. Cedar H., Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009, 10:295-304.
113. Laird P.W. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 2010, 11:191-203.
114. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007, 8:253-262.
115. Cang S., Lu Q., Ma Y., Liu D. Clinical advances in hypomethylating agents targeting epigenetic pathways. Curr Drug Targets 2010, 10:539-545.
116. Tan J., Cang S., Ma Y., Petrillo R.L., Liu D. Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol 2010, 3:5.
117. Rose N.R. The adjuvant effect in infection and autoimmunity. Clin Rev Allergy Immunol 2008, 34:279-282.
118. Didierlaurent A.M., Morel S., Lockman L., Giannini S.L., Bisteau M., Carlsen H., et al. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol 2009, 183:6186-6197.
119. Diebold S.S. Recognition of viral single-stranded RNA by Toll-like receptors. Adv Drug Deliv Rev 2008, 60:813-823.
120. Heal K.G., Taylor-Robinson A.W. Tomatine adjuvantation of protective immunity to a major pre-erythrocytic vaccine candidate of malaria is mediated via CD8+ T cell release of IFN-gamma. J Biomed Biotechnol 2010, 2010:834326.
121. Hedhli D., Dimier-Poisson I., Judge J.W., Rosenberg B., Mevelec M.N. Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant. Vaccine 2009, 27:2274-2281.
122. Liu C., Lou Y., Lizee G., Qin H., Liu S., Rabinovich B., et al. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J Clin Invest 2008, 118:1165-1175.
123. Maraskovsky E., Schnurr M., Wilson N.S., Robson N.C., Boyle J., Drane D. Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant. Immunol Cell Biol 2009, 87:371-376.
124. Ryan E.J., McNeela E., Murphy G.A., Stewart H., O'Hagan D., Pizza M., et al. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells. Infect Immun 1999, 67:6270-6280.
125. Scott-Algara D., Mancini-Bourgine M., Fontaine H., Pol S., Michel M.L. Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination. PLoS One 2010, 5:e8761.
126. Sun H.X., Xie Y., Ye Y.P. Advances in saponin-based adjuvants. Vaccine 2009, 27:1787-1796.
127. Vandepapeliere P., Horsmans Y., Moris P., Van Mechelen M., Janssens M., Koutsoukos M., et al. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vaccine 2008, 26:1375-1386.
128. Vicente-Suarez I., Brayer J., Villagra A., Cheng F., Sotomayor E.M. TLR5 ligation by flagellin converts tolerogenic dendritic cells into activating antigen-presenting cells that preferentially induce T-helper 1 responses. Immunol Lett 2009, 125:114-118.
129. Wu X., Gowda N.M., Kumar S., Gowda D.C. Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J Immunol 2010, 184:4338-4348.
130. Klinker M.W., Lundy S.K. Multiple mechanisms of immune suppression by B lymphocytes. Mol Med 2012, 18:123-137.
131. Meda F., Folci M., Baccarelli A., Selmi C. The epigenetics of autoimmunity. Cell Mol Immunol 2011, 8:226-236.
132. Balada E., Ordi-Ros J., Vilardell-Tarres M. DNA methylation and systemic lupus erythematosus. Ann N Y Acad Sci 2007, 1108:127-136.
133. Zhou Y., Lu Q. DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients. Autoimmun Rev 2008, 7:376-383.
134. Lu Q., Wu A., Richardson B.C. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol 2005, 174:6212-6219.
135. Oelke K., Lu Q., Richardson D., Wu A., Deng C., Hanash S., et al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum 2004, 50:1850-1860.
136. Karouzakis E., Gay R.E., Michel B.A., Gay S., Neidhart M. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2009, 60:3613-3622.
137. Nile C.J., Read R.C., Akil M., Duff G.W., Wilson A.G. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum 2008, 58:2686-2693.
138. Chiang E.P., Wang Y.C., Chen W.W., Tang F.Y. Effects of insulin and glucose on cellular metabolic fluxes in homocysteine transsulfuration, remethylation, S-adenosylmethionine synthesis, and global deoxyribonucleic acid methylation. J Clin Endocrinol Metab 2009, 94:1017-1025.